Home/Papyrus Therapeutics/Prof James Lorens, PhD
PJ

Prof James Lorens, PhD

Board Director & SAB Chair

Papyrus Therapeutics

Papyrus Therapeutics Pipeline

DrugIndicationPhase
PYTX-004Ovarian Cancer (incl. Clear Cell)IND-Enabling
PYTX-004 + IOSolid Tumors (Combination)Preclinical